PP2A激活的目标是神经母细胞瘤中的MYCN
Nazia Nazam1, Shamza Manzoor2, Maryam Shaikh1
1Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
Cell death & disease
|January 15, 2026
概括
赛林/氨酸蛋白酸酶2A (PP2A) 的药理活性降低了高危神经母细胞瘤 (HR-NBL) 中的MYCN表达和瘤生长. 这表明PP2A激活剂是HR-NBL的潜在治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 神经母细胞瘤 (NBL) 是一种常见的儿童癌症,高风险患者 (HR-NBL) 的治疗结果不佳.
- MYCN放大是HR-NBL的一个关键驱动因素,但直接准一直没有成功.
- 氨酸/氨酸蛋白酸酶2A (PP2A) 作为瘤抑制剂,但在NBL中受到抑制.
研究的目的:
- 调查MYCN是否是PP2A的标,以及PP2A的重新激活是否在NBL中具有瘤抑制作用.
- 评估药理PP2A激活的表型,表观遗传和体内影响.
主要方法:
- 在NBL模型中使用了新的PP2A激活器 (ATUX-1215,ATUX-5800).
- 对MYCN mRNA,酸化和蛋白质水平的评估影响.
- 分析了表观遗传变化,包括MYCN促进体中的H3K27ac和RNA Pol II CTD/BRD4酸化.
主要成果:
- PP2A激活剂显著降低了MYCN mRNA和蛋白质表达以及MYCN酸化.
- 激活PP2A降低了MYCN促进体的H3K27ac丰富,并导致RNA Pol II CTD和BRD4.4的低酸化.
- 药理学PP2A激活在体内抑制了瘤生长,在瘤样本中证实了MYCN表达的降低.
结论:
- PP2A的药理反应有效地针对NBL中的MYCN.
- 在NBL模型中,PP2A激活显示出显著的瘤抑制作用.
- 向PP2A代表了高风险神经母细胞瘤的一个有前途的治疗策略.
更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
2.1K
09:45Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
11.7K
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
